Modern tendencies of fundamental and applied research in dermatology (according to the pages of regulatory documents of Russian Federation and foreign journals)

The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Search result: 0

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia

Frigo N.V.

Moscow Sientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia, 119071

ORCID: 0000-0001-6231-971X

Kitaeva N.V.

Moscow Scientic and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia

Kuznetsov S.L.

I.M. Sechenov First Moscow State Medical University

Modern tendencies of fundamental and applied research in dermatology (according to the pages of regulatory documents of Russian Federation and foreign journals)

Authors:

Potekaev N.N., Frigo N.V., Kitaeva N.V., Kuznetsov S.L.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2019;18(6): 675‑688

DOI: 10.17116/klinderma201918061675

Read: 3611 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Potekaev NN, Frigo NV, Kitaeva NV, Kuznetsov SL. Modern tendencies of fundamental and applied research in dermatology (according to the pages of regulatory documents of Russian Federation and foreign journals). Russian Journal of Clinical Dermatology and Venereology. 2019;18(6):675‑688. (In Russ.)
https://doi.org/10.17116/klinderma201918061675

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)

Использование инфографики авторами научных работ

Close metadata

Abstract:

In this article, we analyze regulatory documents related to planning and conducting the research in Russian Federation. The priorities include the development of medical science and innovation in the field of healthcare and the achievement of a world-class level, the integration of Russian medical science into the global scientific space, increasing the effectiveness of fundamental and applied research, the development of personalized and translational medicine Research is conducted within designated scientific platforms using approved critical technologies. Based on the analysis of the topics of the original articles published in highly rated foreign journals in dermatology, the main trends in scientific research in dermatology are identified. The most demanded nosological forms for studying are malignant neoplasms of the skin, psoriasis and atopic dermatitis. The priority of fundamental research is to study the pathogenesis of diseases and malignant neoplasms of the skin, the search for targets for biological therapy; the priority of applied research is in studying the effectiveness of therapeutic agents, including drugs for biological therapy, diagnostics, clinical presentation of dermatoses, risk factors and predicting the course and outcomes of diseases.

Keywords:

dermatology

fundamental research

applied research

medical science development

Authors:

Potekaev N.N.

Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, Moscow, Russia

Frigo N.V.

Moscow Sientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia, 119071

ORCID: 0000-0001-6231-971X

Kitaeva N.V.

Moscow Scientic and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia

Kuznetsov S.L.

I.M. Sechenov First Moscow State Medical University

Close metadata

References:

Rasporyazhenie Pravitel’stva Rossijskoj Federatsii ot 28 dekabrya 2012 g. №2580-r «O Strategii razvitiya meditsinskoj nauki v Rossijskoj Federatsii na period do 2025 goda». (In Russ.)
Prikaz Ministerstva zdravookhraneniya Rossijskoj Federatsii ot 30 aprelya 2013 g. №281 «Ob utverzhdenii nauchnykh platform meditsinskoj nauki». (In Russ.)
Prikaz Ministerstva zdravookhraneniya Rossijskoj Federatsii ot 23 sentyabrya 2015 g. №674 «O vnesenii izmenenij v nauchnye platformy meditsinskoj nauki, utverzhdennye prikazom Ministerstva zdravookhraneniya Rossijskoj Federatsii ot 30 aprelya 2013 g. №281». (In Russ.)
Ukaz Prezidenta Rossijskoj Federatsii ot 7 iyulya 2011 g. №899 «Ob utverzhdenii prioritetnykh napravlenij razvitiya nauki, tekhnologij i tekhniki v Rossijskoj Federatsii i Perechnya kriticheskikh tekhnologij Rossijskoj Federatsii». (In Russ.)
Ukaz Prezidenta Rossijskoj Federatsii ot 1 dekabrya 2016 g. №642 «O Strategii nauchno-tekhnologicheskogo razvitiya Rossijskoj Federatsii». (In Russ.)
Jain KK. Personalized Medicine. Decision Resources Inc. Waltham, MA, USA. 1998.
Prikaz Ministerstva zdravookhraneniya Rossijskoj Federatsii ot 24 aprelya 2018 g. №186 «Ob utverzhdenii Kontseptsii prediktivnoj, preventivnoj i personalizirovannoj meditsiny». (In Russ.)
Paltsev MA, Belushkina NN. Translational medicine is a new stage in the development of molecular medicine. Molec Med. 2012;4:3-6. (In Russ.) https://molmedjournal.ru/ru/molecmed-2012-04-0
Ukaz Prezidenta Rossijskoj Federatsii ot 7 maya 2018 g. №204 «O nacional’nykh tselyakh i strategicheskikh zadachakh razvitiya Rossijskoj Federatsii na period do 2024 goda». (In Russ.)
Prikaz Ministerstva zdravookhraneniya Rossijskoj Federatsii ot 1 fevralya 2019 g. №42 «Ob utverzhdenii vedomstvennoj tselevoj programmy “Razvitie fundamental’noj, translyatsionnoj i personalizirovannoj meditsiny”». (In Russ.)
Okhovat J, Beaulieu D, Tsao H, et al. The first 30 years of the American Academy of Dermatology skin cancer screening program: 1985-2014. J Am Acad Dermatol. 2018;79(5):884-891.e3.
Mirza F, Tuggle C, Zogg C, et al. Epidemiology of malignant cutaneous granular cell tumors: A US population-based cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database. J Am Acad Dermatol. 2018;78(3):490-497.e1.
Yuki A, et al. CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases. J Am Acad Dermatol. 2018;79(6):1039-1046.
Lohcharoenkal W, Mahapatra K, Pasquali L, et al. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis. J Invest Dermatol. 2018;138(4):882-892.
Liu S, Lin C, Lu J, et al. miR-596 Modulates Melanoma Growth by Regulating Cell Survival and Death. J Invest Dermatol. 2018;138(4):911-921.
Strober B, et al. Characterization of disease burden, comorbidities, and treatment use in a large, US-based cohort: Results from the Corrona Psoriasis Registry. J Am Acad Dermatol. 2018;78(2):323-332.
Elewski B, et al. Rich Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial. J Am Acad Dermatol. 2018;78(1):90-99.e1.
Lebwohl M, et al. Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT). J Am Acad Dermatol. 2018;79(2):266-276.e5.
Gottlieb A, et al. Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2). J Am Acad Dermatol. 2018;79(2):302-314.e6.
Puig Lluís, et al. Effect of secukinumab on quality of life and psoriasis-related symptoms: A comparative analysis versus ustekinumab from the CLEAR 52-week study. J Am Acad Dermatol. 2018;78(4):741-748.
Lebwohl M, et al. Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials l. J Am Acad Dermatol. 2018;78(1):81-89.e5.
Egeberg A, et al. Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3. J Am Acad Dermatol. 2018;79(1):104-109. https://doi.org/10.1016/j.jaad.2018.02.074
Papp K, et al. Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial. J Am Acad Dermatol. 2018;79(2):277-286. https://doi.org/10.1016/j.jaad.2018.03.037
Winthrop KL, Korman N, Abramovits W, et al. T-cell–mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatment. J Am Acad Dermatol. 2018;78(6):1149-1155.e1.
Locker F, Vidali S, Holub B, et al. Lack of Galanin Receptor 3 Alleviates Psoriasis by Altering Vascularization, Immune Cell Infiltration, and Cytokine Expression. J Invest Dermatol. 2018;138(1):199-207.
Eckert L, Gupta S, Amand C, et al. The burden of atopic dermatitis in US adults: Health care resource utilization data from the 2013 National Health and Wellness Survey. J Am Acad Dermatol. 2018;78(1):54-61.e1.
Thorsti A, et al. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: A systematic review and meta-analysis. J Am Acad Dermatol. 2018;79(3):448-456.e30.
Gooderham M, Chih-Ho Hong H, Eshtiaghi P, et al. Papp Dupilumab: A review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol. 2018;78(1):62-69.e1.
Hamann C, Thyssen J. Monoclonal antibodies against interleukin 13 and interleukin 31RA in development for atopic dermatitis. J Am Acad Dermatol. 2018;78(3)Supplement 1:S37-S42.
Zebda R, Paller A. Phosphodiesterase 4 inhibitors. J Am Acad Dermatol. 2018;78(3)Supplement 1:S43-S52.
Cotter D, Schairer D, Eichenfield L. Emerging therapies for atopic dermatitis: JAK inhibitors. J Am Acad Dermatol. 2018;78(3)Supplement 1:S53-S62.
Sasso O, Summa M, Armirotti A, et al. The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of Allergic Dermatitis. J Invest Dermatol. 2018;138(3):562-569.

Log in to the site using your account in one of the services

Registration

Last Name

Name

Middle Name

E-mail

Phone

Address

Country

Zip

City

Region

Street

Home

Apartmen

Legal entity name

ИНН

КПП

Password

Password

Repeat password

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.